Liver biopsy and related techniques in pathological diagnosis
-
摘要: 肝脏病理学检查在指导临床治疗和评估疾病预后方面具有重要的地位和作用,特别是对疑难肝脏疾病的确诊至关重要。通过开展肝穿刺活组织检查,选用合理的病理学技术方法,有助于病理医生观察肝脏组织的形态学改变,为疾病的诊断、鉴别诊断以及明确病因提供重要参考。介绍了肝活组织病理学诊断的常用技术,以提高临床医师对肝脏病理学改变的认识水平,加强临床与病理联系,为肝脏疾病、特别是疑难肝病的确诊提供有力的帮助。Abstract: Liver pathological examination plays an important role in guiding clinical treatment and evaluating disease prognosis, especially in the diagnosis of difficult liver diseases. The application of liver biopsy and proper pathological techniques helps pathologists to observe the morphological changes of the liver and thus provides a reference for disease diagnosis, differential diagnosis, and clarification of etiology.This article introduces the commonly used techniques for liver biopsy, in order to improve the understanding of liver pathological changes among clinicians, strengthen the association between clinical practice and pathology, and provide help to the diagnosis of liver diseases, especially difficult liver diseases.
-
Key words:
- liver diseases /
- biopsy /
- pathology /
- diagnosis
-
[1]TAPPER EB, LOK AS.Use of liver imaging and biopsy in clinical practice[J].N Engl J Med, 2017, 377 (8) :756-768. [2]CONG WM.Liver biopsy in the diagnosis of clinical pathology principles[J].Chin J Clin Exp Pathol, 2012, 28 (4) :359-361. (in Chinese) 丛文铭.肝脏穿刺活检诊断临床病理学要则[J].临床与实验病理学杂志, 2012, 28 (4) :359-361. [3]ROCKEY DC, CALDWELL SH, GOODMAN ZD, et al.Liver biopsy[J].Hepatology, 2009, 49 (3) :1017-1044. [4]GRANT A, NEUBERGER J.Guidelines on the use of liver biopsy in clinical practice.British Society of Gastroenterology[J].Gut, 1999, 45 (Suppl 4) :v1-v11. [5]HE ZY, ZHAO XY.Liver histopathology in dealing with patients with unknown causes[J].J Pract Hepatol, 2018, 21 (1) :10-13. (in Chinese) 何志颖, 赵新颜.肝组织病理学检查在不明原因肝病诊治中的应用[J].实用肝脏病杂志, 2018, 21 (1) :10-13. [6]PAREKH PJ, MAJITHIA R, DIEHL DL, et al.Endoscopic ultrasound-guided liver biopsy[J].Endosc Ultrasound, 2015, 4 (2) :85-91. [7]ZHOU JH, LU Q, YU BY, et al.Application of coaxial technique in 150 cases of ultrasound-guided liver biopsy[J].Chin J Evidbased Med, 2018, 18 (4) :295-297. (in Chinese) 周洁宏, 卢强, 于波洋, 等.同轴技术在150例超声引导肝脏穿刺活检中的应用[J].中国循证医学杂志, 2018, 18 (4) :295-297. [8]CLARK TW, MCCANN JW, SALSAMENDI J, et al.Optimizing needle direction during transjugular liver biopsy provides superior biopsy specimens[J].Cardiovasc Intervent Radiol, 2014, 37 (6) :1540-1545. [9]KIM SJ, WON JH, KIM YB, et al.Plugged percutaneous biopsy of the liver in living-donor liver transplantation recipients suspected to have graft rejection[J].Acta Radiol, 2017, 58 (7) :771-777. [10]ATAR E, BEN AZ, BACHAR GN, et al.A comparison of transjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an"inhouse"protocol for selecting the procedure of choice[J].Cardiovasc Intervent Radiol, 2010, 33 (3) :560-564. [11]SHAH ND, SASATOMI E, BARON TH.Endoscopic ultrasoundguided parenchymal liver biopsy:Single center experience of a new dedicated core needle[J].Clin Gastroenterol Hepatol, 2017, 15 (5) :784-786. [12]National Hepatobiliary Tumor and Transplantation Pathology Cooperative Group.Guidelines for pathological diagnosis and grading of common diseases after liver transplantation (Part 1) [J].Chin JOrgan Transplant, 2008, 29 (1) :49-51. (in Chinese) 全国肝胆肿瘤及移植病理协作组.肝移植术后常见病变的病理诊断与分级指南 (I) [J].中华器官移植杂志, 2008, 29 (1) :49-51. [13]Chinese Expert Consensus Statement Chinese Society of Liver Cancer (CSLC) , Chinese Society of Clinical Oncology (CSCO) , Liver Cancer Group, Chinese Society of Hepatology, et al.Experts consensus on pathological diagnosis of primary liver cancer[J].J Clin Hepatol, 2011, 27 (4) :645-647. (in Chinese) 中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学会肝癌学组, 等.原发性肝癌规范化病理诊断方案专家共识[J].临床肝胆病杂志, 2011, 27 (4) :645-647. [14]PALMER T, GEORGIADES I, TREANOR D, et al.Improved tissue sections for medical liver biopsies:A comparison of 16 vs 18 g biopsy needles using digital pathology[J].J Clin Pathol, 2014, 67 (5) :415-419. [15]CLARK I, TORBENSON MS.Immunohistochemistry and special stains in medical liver pathology[J].Adv Anat Pathol, 2017, 24 (2) :99-109. [16]PENG XX, WANG TL.Clinicopathology of liver diseases[M].Beijing:Chemical Industry Press, 2010:20-53. (in Chinese) 彭向欣, 王泰龄.肝脏疾病临床病理学[M].北京:化学工业出版社, 2010:20-53. [17]SAXENA R.Practical hepatic pathology:A diagnostic approach[M].2th Edition.PA:Elsevier, 2018. [18]ZHANG J, LI MR, WANG TL.Special staining and immunohistochemical staining for liver histology[J].Chin J Diagn Pathol, 2001, 8 (3) :48-49. (in Chinese) 张晶, 李美蓉, 王泰龄.肝组织学检查常用的特殊染色及免疫组化染色[J].诊断病理学杂志, 2001, 8 (3) :48-49. [19]XIAN ZH, QIN C, CONG WM.Application of special staining in pathological diagnosis of liver biopsy[J].Chin J Clin Exp Pathol, 2013, 29 (4) :424-427. (in Chinese) 冼志红, 秦纯, 丛文铭.重视特殊染色在肝脏活检病理诊断中的应用[J].临床与实验病理学杂志, 2013, 29 (4) :424-427. [20]ZHANG HL, XU YG, WANG TL.Application of special staining in pathological diagnosis of liver[J].Chin J Diagn Pathol, 2017, 24 (3) :238-239. (in Chinese) 张红雷, 徐游贵, 王泰龄.特殊染色法在肝脏病理诊断中的应用[J].诊断病理学杂志, 2017, 24 (3) :238-239. [21]ZHAO P, ZHAO M, JI YJ, et al.Detection of HIV-1 RNA and p24 antigen in HIV l-infected human liver[J].Chin J AIDS STD, 2009, 15 (6) :575-577. (in Chinese) 赵鹏, 赵敏, 吉英杰, 等.HIV/AIDS病人肝脏HIV-1 RNA和p24抗原的检测[J].中国艾滋病性病, 2009, 15 (6) :575-577. [22]RANASINGHE S, WICKREMASINGHE R, HULANGAMUWA S, et al.Polymerase chain reaction detection of leishmania DNA in skin biopsy samples in Sri Lanka where the causative agent of cutaneous leishmaniasis is leishmania donovani[J].Mem Inst Oswaldo Cruz, 2015, 110 (8) :1017-1023. [23]MEGHDADI H, KHOSRAVI AD, GHADIRI AA, et al.Detection of mycobacterium tuberculosis in extrapulmonary biopsy samples using PCR targeting IS6110, rpo B, and nested-rpoB PCR cloning[J].Front Microbiol, 2015, 6:675. [24]HAN JQ, ZHONG YW, REN XQ, et al.Application of special staining in pathological diagnosis of liver[J].Med J Chin PLA, 2011, 36 (5) :459-462. (in Chinese) 韩佳琪, 钟彦伟, 任晓强, 等.慢性乙肝患者石蜡包埋肝组织中HBV ccc DNA定量检测方法的建立[J].解放军医学杂志, 2011, 36 (5) :459-462. [25]LEFKOWITCH JH.Scheuer's liver biopsy interpretation[M].9th Edition.New York:Elsevier, 2016:398-400. [26]KARAGKOUNIS G, TORBENSON MS, DANIEL HD, et al.Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases[J].Cancer, 2013, 119 (23) :4137-4144. [27]LOES IM, IMMERVOLL H, SORBYE H, et al.Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases[J].Int J Cancer, 2016, 139 (3) :647-656.
本文二维码
计量
- 文章访问数: 2403
- HTML全文浏览量: 78
- PDF下载量: 496
- 被引次数: 0